Cited by 178Cytokine Signaling Pathways and InteractionsProstate Cancer Treatment and ResearchCancer Cells and Metastasis

The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.

JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells

Kroon, Paula, Berry, Paul A., Stower, Michael J., Rodrigues, Greta, Mann, Vincent M., Simms, Matthew, Bhasin, Deepak, Chettiar, Somsundaram, Li, Chenglong, Li, Pui-Kai, Maitland, Norman J., Collins, Anne T.·2013·Cancer Research

DOI 10.1158/0008-5472.can-13-0874

Published version of a preprint

Open this paper in CoChat — free account

Abstract

Interleukin (IL)-6 overexpression and constitutive STAT3 activation occur in many cancers, including prostate cancer. However, their contribution to prostate stem and progenitor cells has not been explored. In this study, we show that stem-like cells from patients with prostate cancer secrete higher levels of IL-6 than their counterparts in non-neoplastic prostate. Tumor grade did not influence the levels of expression or secretion. Stem-like and progenitor cells expressed the IL-6 receptor gp80 with concomitant expression of pSTAT3. Blockade of activated STAT3, by either anti-IL-6 antibody siltuximab (CNTO 328) or LLL12, a specific pSTAT3 inhibitor, suppressed the clonogenicity of the stem-like cells in patients with high-grade disease. In a murine xenograft model used to determine the in vivo effects of pSTAT3 suppression, LLL12 treatment effectively abolished outgrowth of a patient-derived castrate-resistant tumor. Our results indicate that the most primitive cells in prostate cancer require pSTAT3 for survival, rationalizing STAT3 as a therapeutic target to treat advanced prostate cancer. Cancer Res; 73(16); 5288–98. ©2013 AACR.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-13-0874

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Prospective identification of tumorigenic breast cancer cells
Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C. E., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,564
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
Bonnet, D. A., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 7,197
Cancer Statistics, 2005
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O'Brien, C. A., Pollett, A. F., Gallinger, S., & Dick, J. E. (2006) · Nature · doi:10.1038/nature05372 · Cited by 4,174
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P. D., Burant, C., Zhang, L., Adsay, V. N., Wicha, M. S., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,419
Self-citation
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells
Collins, A. T., Berry, P. A., Hyde, C. F., Stower, M. J., & Maitland, N. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2018 · Cited by 2,821
Self-citation
Stat3 as an Oncogene
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
Hu, Y., & Smyth, G. K. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.008 · Cited by 2,084

Show all 49 references

Sorted by citations

Items 101–178 of 178

ARPC1A is regulated by STAT3 to inhibit ferroptosis and promote prostate cancer progression
Ji, J., Li, H., Wang, W., Yuan, B., & Shen, T. (2022) · Human Cell · doi:10.1007/s13577-022-00754-w · Cited by 23
Shrinking the battlefield in cancer therapy: Nanotechnology against cancer stem cells
Fernandes, Q., Therachiyil, L., Khan, A. Q., Bedhiafi, T., Korashy, H. M., Bhat, A. A., & Shahab Uddin, M. S. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106586 · Cited by 26
Prostate Cancer Stem Cells: Biology and Treatment Implications
Koukourakis, I. M., Platoni, K., Kouloulias, V., Arelaki, S., & Zygogianni, A. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914890 · Cited by 23
Tumor heterogeneity and therapy resistance - implications for future treatments of prostate cancer
Frame, F. M., Noble, A. R., Klein, S., Walker, H. F., Suman, R., Kasprowicz, R., Mann, V. M., Simms, M. S., & Maitland, N. J. (2017) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2017.34 · Cited by 23
Self-citation
Overexpression of SOCS3 mediated by adenovirus vector in mouse and human castration-resistant prostate cancer cells increases the sensitivity to NK cells in vitro and in vivo
Yoneda, T., Kunimura, N., Kitagawa, K., Fukui, Y., Saito, H., Narikiyo, K., Ishiko, M., Otsuki, N., Nibu, K., Fujisawa, M., et al. (2019) · Cancer Gene Therapy · doi:10.1038/s41417-018-0075-5 · Cited by 22
FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer
Zhou, Y., Ou, L., Xu, J., Yuan, H., Luo, J.-H., Shi, B., Li, X., Yang, S., & Wang, Y. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03933-z · Cited by 20
Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways
Therachiyil, L., Hussein, O., Shahab Uddin, M. S., & Korashy, H. M. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.003 · Cited by 24
Urinary microRNAs and Their Significance in Prostate Cancer Diagnosis: A 5-Year Update
Juráček, J., Mądrzyk, M., Staník, M., & Slabý, O. (2022) · Cancers · doi:10.3390/cancers14133157 · Cited by 21
Exogenous IL‐6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild‐type, African American PCa cells
Teslow, E. A., Bao, B., Dyson, G. E., Legendre, C., Mitrea, C., Sakr, W., Carpten, J. D., Powell, I. J., & Bollig-Fischer, A. B. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12316 · Cited by 21
Ribonucleic acid interference knockdown of IL-6 enhances the efficacy of cisplatin in laryngeal cancer stem cells by down-regulating the IL-6/STAT3/HIF1 pathway
Fu, Q., Liu, P., Sun, X., Huang, S., Han, F., Zhang, L., Xu, Y., & Liu, T. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0448-0 · Cited by 22
The Molecular Biology of Prostate Cancer Stem Cells: From the Past to the Future
Zhou, Y., Li, T., Jia, M., Dai, R., & Wang, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087482 · Cited by 22
Therapeutic implications of cancer stem cells in prostate cancer
Banerjee, P., Kapse, P., Siddique, S., Kundu, M., Choudhari, J., Mohanty, V., Malhotra, D., Gosavi, S., Gacche, R. N., & Kundu, G. C. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0714 · Cited by 19
Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer
Erb, H. H. H., Bodenbender, J., Handle, F., Diehl, T., Donix, L., Tsaur, I., Gleave, M. E., Haferkamp, A., Huber, J. C., Fuessel, S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237248 · Cited by 20
Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction
Alemohammad, H., Asadzadeh, Z., azad, R. M., Hemmat, N., Najafzadeh, B., Vasefifar, P., Najafi, S., & Baradaran, B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118337 · Cited by 21
Identification of key genes involved in JAK/STAT pathway in colorectal cancer
Yue, Y., Zhang, Q., Wu, S., Wang, S., Cui, C., Yu, M., & Sun, Z. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.10.007 · Cited by 20
Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways
Sonawala, K., Ramalingam, S., & Sellamuthu, I. (2022) · Cells · doi:10.3390/cells11213492 · Cited by 19
Cancer stem cells: Bridging microenvironmental interactions and clinical therapy
Wang, H., Li, J., Du, F., & Deng, H. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70406 · Cited by 20
Harvesting Human Prostate Tissue Material and Culturing Primary Prostate Epithelial Cells
Frame, F. M., Pellacani, D., Collins, A. T., & Maitland, N. J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3724-0_12 · Cited by 18
Self-citation
Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer
Zamora, I., Freeman, M. R., Encı́o, I., & Rotinen, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813673 · Cited by 20
Transmembrane and coiled-coil domain family 3 (TMCC3) regulates breast cancer stem cell and AKT activation
Wang, Y., Chan, Y., Hung, T., Hung, J., Kuo, M.-W., Wang, S., Huang, Y., Lin, Y., Chen, S., Yu, J., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01729-1 · Cited by 18
Curcumin Innovative Delivery Forms: Paving the ‘Yellow Brick Road’ of Antitumoral Phytotherapy
Henriques, M. C., Faustino, M. A. F., & Braga, S. S. (2020) · Applied Sciences · doi:10.3390/app10248990 · Cited by 18
STAT3 inactivation suppresses stemness properties in gastric cancer stem cells and promotes Th17 in Treg/Th17 balance
Hajimoradi, M., Rezalotfi, A., Esmaeilnejad-Ahranjani, P., Hassan, Z. M., & Ebrahimi, M. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109048 · Cited by 17
A role for paracrine interleukin‐6 signaling in the tumor microenvironment in prostate tumor growth
Yu, S., Maynard, J. P., Vaghasia, A. M., Marzo, A. M. D., Drake, C. G., & Sfanos, K. S. (2018) · The Prostate · doi:10.1002/pros.23726 · Cited by 16
Signal transducer and activator of transcription 3 (STAT3) promoter methylation and expression in pituitary adenoma
Valiulyte, I., Steponaitis, G., Skiriutė, D., Tamašauskas, A., & Vaitkienė, P. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0434-3 · Cited by 16
Combination Blockade of the IL6R/STAT-3 Axis with TIGIT and Its Impact on the Functional Activity of NK Cells against Prostate Cancer Cells
Ochoa, S. G., Téllez‐Bañuelos, M. C., Méndez-Clemente, A. S., Bravo‐Cuéllar, A., Hernández‐Flores, G., Palafox-Mariscal, L. A., Haramati, J., Pedraza‐Brindis, E. J., Sánchez-Reyes, K., & Ortiz‐Lazareno, P. C. (2022) · Journal of Immunology Research · doi:10.1155/2022/1810804 · Cited by 16
Metabolic characterization of sphere‐derived prostate cancer stem cells reveals aberrant urea cycle in stemness maintenance
Luo, Y., Yu, J., Lin, Z., Wang, X., Zhao, J., Liu, X., Qin, W., & Xu, G. (2024) · International Journal of Cancer · doi:10.1002/ijc.34967 · Cited by 15
Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells
Civenni, G., Albino, D., Shinde, D. A., Vázquez, R., Merulla, J., Kokanovic, A., Mapelli, S. N., Carbone, G. M., & Catapano, C. V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00385 · Cited by 16
Stem cells and the role of ETS transcription factors in the differentiation hierarchy of normal and malignant prostate epithelium
Archer, L. K., Frame, F. M., & Maitland, N. J. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.05.006 · Cited by 15
Self-citation
Vitamin D deficiency promotes prostatic hyperplasia in middle-age mice through exacerbating local inflammation
Zhang, Z., Luo, B., Xu, S., Fu, L., Chen, Y., Zhang, C., Wang, H., Xie, D., & Xu, D. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.04.006 · Cited by 15
Characteristics of Cancer Stem Cells and Their Potential Role in Endometrial Cancer
Frąszczak, K., & Barczyński, B. (2024) · Cancers · doi:10.3390/cancers16061083 · Cited by 13
Enzalutamide-Resistant Progression of Castration-Resistant Prostate Cancer Is Driven via the JAK2/STAT1-Dependent Pathway
Luo, Y., Yang, X., Basourakos, S. P., Zuo, X., Wei, D., Zhao, J., Li, M., Li, Q., Feng, T., Guo, P., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.652443 · Cited by 13
Regulation of cancer stem cells by RING finger ubiquitin ligases.
Kang, B., & Sun, X.-H. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2306-9759.2014.01.01 · Cited by 12
New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to Clinic
Cai, M., Zheng, F., Ren, Y.-Z., Zhen, C., Fu, D., Song, X., Li, Q., Qu, Y., Chen, Z., & Zhao, S. (2025) · Research · doi:10.34133/research.0791 · Cited by 12
Prostate cancer stem cells and their targeted therapies
Su, H., Huang, L., Zhou, J., & Yang, G. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1410102 · Cited by 10
Natural products targeting cancer stem cells: a promising therapeutic approach
Opara, J. K., Sanchez, S., Thomas, S. M., & Anant, S. (2025) · Exploration of Drug Science · doi:10.37349/eds.2025.1008106 · Cited by 10
Cell-cell interactions that drive tumorigenesis in Drosophila
Enomoto, M., & Igaki, T. (2022) · Fly · doi:10.1080/19336934.2022.2148828 · Cited by 10
STAT3 in Prostate Cancer: Whom Should We Treat and When?
Čulig, Z. (2016) · European Urology · doi:10.1016/j.eururo.2016.06.034 · Cited by 10
YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations
Cunningham, R., Jia, S., Purohit, K. P., Salem, O., Hui, N. S., Lin, Y., Carragher, N. O., & Hansen, C. G. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1190 · Cited by 11
Expression and regulation of aldehyde dehydrogenases in prostate cancer
Ibrahim, A. I. M., Sadiq, M., Frame, F. M., Maitland, N. J., & Pors, K. (2018) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.07 · Cited by 9
Self-citation
Ginger - Cultivation and Use
Kaushik, P., & Ahmad, R. S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102135 · Cited by 8
Cancer Stem Cells
Li, Y., & Huang, J. (2017) · Molecular pathology library · doi:10.1007/978-3-319-64096-9_7 · Cited by 7
An in vitro system to characterize prostate cancer progression identified signaling required for self‐renewal
Salah, M., Nishimoto, Y., Kohno, S., Kondoh, A., Kitajima, S., Muranaka, H., Nishiuchi, T., Ibrahim, A., Yoshida, A., & Takahashi, C. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22444 · Cited by 6
IL-4 Counteracts the Cytotoxic Effects of Peripheral Blood Mononuclear Cells on Hormone-sensitive Prostate Cancer Cells
Erb, H. H. H., Čulig, Z., & Stope, M. B. (2021) · In Vivo · doi:10.21873/invivo.12465 · Cited by 5
The Role of Long Non-Coding RNAs in Epithelial-Mesenchymal Transition-Related Signaling Pathways in Prostate Cancer
Shen, D., Peng, H., Xia, C., Deng, Z., Tong, X., Wang, G., & Qian, K. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.939070 · Cited by 5
Effects of gametogenetin‐binding protein 2 on proliferation, invasion and migration of prostate cancer PC‐3 cells
Yang, Z., Wang, Y., & Ma, L. (2019) · Andrologia · doi:10.1111/and.13488 · Cited by 5
Targeting Cancer Stem Cells—A Renewed Therapeutic Paradigm
Amey, C. L., & Karnoub, A. E. (2017) · touchREVIEWS in Oncology & Haematology · doi:10.17925/ohr.2017.13.01.45 · Cited by 4
Molecular Mechanisms Involved in the Transition of Prostate Cancer Cells from Androgen Dependant to Castration Resistant State
Forootan, S. S., Hussain, S. A., Aachi, V., Foster, C. S., & Ke, Y. (2014) · Journal of Andrology and Gynaecology · doi:10.13188/2332-3442.1000017 · Cited by 5
CD133 as Biomarker and Therapeutic Target in Gynecologic Malignancies
Fiore, R. D., Suleiman, S., & Calleja‐Agius, J. (2023) · Interdisciplinary cancer research · doi:10.1007/16833_2023_139 · Cited by 4
The Biological Effects of Interleukin-6 and Their Clinical Applications in Autoimmune Diseases and Cancers
Yang, D. (2017) · Rheumatica Acta Open Access · doi:10.17352/aroa.000003 · Cited by 4
Expression and role of HEPIS in breast cancer
Hu, F., Zhang, Y., Li, M., Bai, Y., & Zhang, X. (2019) · Oncology Letters · doi:10.3892/ol.2019.10993 · Cited by 4
Prostate Cancer, JAK/STAT3 Dysregulation, and Flavonoids: Is There a Possible Link?
Uivaroşi, V., Miricescu, D., Văcăroiu, I. A., Spinu, D. A., Ștefani, C., Stanciu, S., Nica, R. I., Stănescu-Spînu, I.-I., Bădoiu, S. C., Nica, S., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020885 · Cited by 3
NANOG Dominates Interleukin-6-Induced Sphere Formation in Prostate Cancer
Seven, D., Tecimel, D., & Bayrak, Ö. F. (2023) · Urology Research and Practice · doi:10.5152/tud.2023.23116 · Cited by 2
Insights into the Biological Properties of Prostate Cancer Stem Cells: Implications for Cancer Progression and Therapy
Poodineh, J., Akhlaghpour, A., Ghaedrahmati, F., Pour, F. K., Shahab Uddin, M. S., Farzaneh, M., & Azizidoost, S. (2024) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x268997231206112056 · Cited by 2
Germicidal and Antineoplastic Activities of Curcumin and Curcumin-Derived Nanoparticles
Makgoo, L., & Mbita, Z. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103076 · Cited by 2
Re: Lin28 Promotes Growth of Prostate Cancer Cells and Activates the Androgen Receptor
Čulig, Z. (2014) · European Urology · doi:10.1016/j.eururo.2013.12.040 · Cited by 2
Introduction to Cancer Stem Cells
Khuda‐Bukhsh, A. R., Samadder, A., & Saha, S. K. (2020) · Springer eBooks · doi:10.1007/978-981-15-5120-8_1 · Cited by 1
STAT3 polymorphisms in North Africa and its implication in breast cancer
Ziadi, W., Boussetta, S., Elkamel, S., PAKSTIS, A. J., Kídd, K. K., Medimegh, I., Elgaaïed, A. B. A., & Cherni, L. (2021) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1744 · Cited by 1
Re: Treatment of Prostate Cancer with Intermittent Versus Continuous Androgen Deprivation: A Systematic Review of Randomized Trials
TOMBAL, B. F. (2014) · European Urology · doi:10.1016/j.eururo.2013.12.041
The preclinical development of novel treatment options for advanced prostate cancer
Kroon, J. (2016) · doi:10.3990/1.9789462331679
Inhibitors of Upstream Inducers of STAT Activation
Kumar, J. (2016) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-42949-6_7
The role of inhibitor of apoptosis (IAP) family member survivin in prostatic disease
McIlwain, D. W. (2017) · IUScholarWorks (Indiana University) · doi:10.7912/c2/328
The prostate cancer stem cell niche: Genetic drivers and therapeutic approaches
Canesin, G. (2020) · Advances in stem cells and their niches · doi:10.1016/bs.asn.2020.09.001
Faculty Opinions recommendation of CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation.
Ben‐Ze'ev, A. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726638605.793550599
Role of cancer stem cells in prostate cancer therapy resistance
Hachem, S., Fakhereddine, H., Yehya, A., & Abou-Kheir, W. G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-16032-5.00006-3
Genomic landscapes and therapeutic perspectives of cancer stem cells in the tumor microenvironment
Shrestha, P., Lee, D., Giri, A., Thi, T.-H. L., & Yook, S. (2025) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-025-00794-y · Cited by 2
Additional file 2 of TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9
Hu, R., Cao, Y., Wang, Y., Zhao, T., Yang, K., Fan, M., Guan, M., Hou, Y., Ying, J., Ma, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25441032
Additional file 3 of TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9
Hu, R., Cao, Y., Wang, Y., Zhao, T., Yang, K., Fan, M., Guan, M., Hou, Y., Ying, J., Ma, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26695338
Additional file 4 of TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9
Hu, R., Cao, Y., Wang, Y., Zhao, T., Yang, K., Fan, M., Guan, M., Hou, Y., Ying, J., Ma, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26695341
Additional file 5 of TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9
Hu, R., Cao, Y., Wang, Y., Zhao, T., Yang, K., Fan, M., Guan, M., Hou, Y., Ying, J., Ma, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26695344
Additional file 6 of TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9
Hu, R., Cao, Y., Wang, Y., Zhao, T., Yang, K., Fan, M., Guan, M., Hou, Y., Ying, J., Ma, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26695347
Additional file 1 of TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9
Hu, R., Cao, Y., Wang, Y., Zhao, T., Yang, K., Fan, M., Guan, M., Hou, Y., Ying, J., Ma, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25440940
Obesogens in Prostate Cancer: An Endocrine and Metabolic Threat
Feijó, M., Fonseca, L. R. S., Kiss‐Toth, E., Socorro, S., & Correia, S. T. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00690-y
XPC restrains cancer stemness by modulating STAT1-SOX2 signaling in non-small cell lung cancerPreprint
Wang, Q.-E., Li, N., Bai, X., Cai, S., Lei, Y., Wang, K. Y., Li, A., Yang, Y., Wang, L., Miao, J., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9002641/v1
ABCG2-autophagy regulatory axis in cancer stem cells: implication in cancer metastasis, recurrence and chemotherapy resistance
Zalpoor, H., Teow, J. Y., Ferdousmakan, S., Golestani, N., Nabi‐Afjadi, M., & Ramasamy, T. S. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02853-9
Canonical Wnt signaling in the regulation of prostate cancer stem cells: a key driver of castration-resistant prostate cancer and a therapeutic opportunity
Li, H., Xu, H., Hou, Y., Ni, Q., Zhang, J., Ma, Y., Nie, X., & Hou, J. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08751-5
Targeting interleukin-6 in immune-mediated inflammatory diseases: Current strategies and emerging technologies
Ji, P., Zhao, P., Guo, W., Cai, S., Hunter, D. J., & Mei, Y. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004273
Lantana camara–derived phytochemical delivery via chitosan nanoparticles suppresses IL-6–driven JAK/STAT3 signaling and androgen-independent prostate cancer progression
Ukwubile, C. A., Famurewa, A. C., Njidda, S., Okoro, R. N., Umar, S., Nettey, H., Babagana, Y., & Mejida, S. (2026) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2026.100870
Natural product derived phytochemicals as modulators of cancer stemness and drug resistance
Qazi, A. K., Parray, M. O., & Syed, S. H. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1940814

Authors: Kroon, P., Berry, P. A., Stower, M. J., Rodrigues, G., Mann, V. M., Simms, M., Bhasin, D., Chettiar, S., Li, C., Li, P.-K., Maitland, N. J., & Collins, A. T.
Affiliations: York Hospital (GB)
ORCID: Li, Chenglong
Li, Pui-Kai
Maitland, Norman J.
Collins, Anne T.
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2013-08-13
Volume: 73
Issue: 16
Pages: 5288-5298
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-13-0874
OpenAlex: W2069303628
Cited by: 175
References: 49
Citations by year: 2026: 8 · 2025: 4 · 2024: 10 · 2023: 13 · 2022: 13 · 2021: 12 · 2020: 10 · 2019: 13 · 2018: 13 · 2017: 15 · 2016: 19 · 2015: 26 · 2014: 18 · 2013: 1
FWCI: 11.41
Type: journal article
Language: en
Open access: closed
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
Funders: Prostate Cancer UK (PG12-01)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords: prostate cancer, cancer stem-like cells, STAT3 activation, interleukin-6, siltuximab, tumor initiation, castration-resistant prostate cancer, therapeutic target
MeSH terms: Aged, Aged, 80 and over, Animals, Anthraquinones, Antibodies, Monoclonal, Humans, Male, Middle Aged, Sulfonamides, Neoplastic Stem Cells, Interleukin-6, Receptors, Interleukin-6, Cell Line, Tumor, STAT3 Transcription Factor, Mice, Janus Kinases, Prostatic Neoplasms, Castration-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks